Search research articles
Contact Us
Filters
Showing results (91-100 of 132) with videos related to
Page
of 14
Sort By:
Cancer Discovery
|
June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
Hikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 20, 2019
MRE11 as a Predictive Biomarker of Outcome After Radiation Therapy in Bladder Cancer
Alexandra K Walker, Katalin Karaszi, Helen Valentine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2015
Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer
Rachel N Grisham, Brooke E Sylvester, Helen Won, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Cell Reports
|
December 21, 2022
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
Timothy N Clinton, Ziyu Chen, Hannah Wise, et al.
Nature
|
November 20, 2014
Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor
Dejan Juric, Pau Castel, Malachi Griffith, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications
Dilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
Nature Communications
|
December 20, 2025
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer
Ziyu Chen, Xinran Tang, Jordan E Eichholz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2026
Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancer
Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran, et al.
European Urology
|
August 18, 2015
Genomic Characterization of Upper Tract Urothelial Carcinoma
John P Sfakianos, Eugene K Cha, Gopa Iyer, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 132) with videos related to
Sort By:
Page
of 14
Cancer Discovery
|
June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
Hikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 20, 2019
MRE11 as a Predictive Biomarker of Outcome After Radiation Therapy in Bladder Cancer
Alexandra K Walker, Katalin Karaszi, Helen Valentine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2015
Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer
Rachel N Grisham, Brooke E Sylvester, Helen Won, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Cell Reports
|
December 21, 2022
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
Timothy N Clinton, Ziyu Chen, Hannah Wise, et al.
Nature
|
November 20, 2014
Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor
Dejan Juric, Pau Castel, Malachi Griffith, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications
Dilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
Nature Communications
|
December 20, 2025
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer
Ziyu Chen, Xinran Tang, Jordan E Eichholz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2026
Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancer
Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran, et al.
European Urology
|
August 18, 2015
Genomic Characterization of Upper Tract Urothelial Carcinoma
John P Sfakianos, Eugene K Cha, Gopa Iyer, et al.
Page
of 14